The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Written informed consent
* Age \> 18 years
* Duraplasty using Neuro-Patch® according to the Instructions for Use
Exclusion Criteria:
* Use in infected regions
* Use in open cerebrocranial traumata
* Use in open spina bifida
* Known hypersensitivity to implant materials
* Pregnancy
* Representation by a legal guardian or under involuntary commitment
Primary outcome measure(s)
Incidence of complications — until follow-up (up to one year after surgery) Incidence of complications, with (potential) causal relationship to Neuro-Patch
Trial sites (4)
Facility
City
Region
Status
Service de Neurochirurgie, Hôpital de la Cavale Blanche
Brest
France
Hopital Pierre Wertheimer - HCL
Bron
France
Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.